Evidence mapPaperPMID 36235571Full record

Trial reportNutrients2022

Oral Erythritol Reduces Energy Intake during a Subsequent

Fabienne Teysseire, Emilie Flad, Valentine Bordier, Aleksandra Budzinska, Nathalie Weltens, Jens F Rehfeld, Christoph Beglinger, Lukas Van Oudenhove, Bettina K Wölnerhanssen, Anne Christin Meyer-Gerspach

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

Fabienne TeysseireSt. Clara Research Ltd. at St. Claraspital, 4002 Basel, Switzerland.ORCID 0000-0001-8602-9960
Emilie FladSt. Clara Research Ltd. at St. Claraspital, 4002 Basel, Switzerland.ORCID 0000-0002-4510-5370
Valentine BordierSt. Clara Research Ltd. at St. Claraspital, 4002 Basel, Switzerland.ORCID 0000-0002-1229-825X
Aleksandra BudzinskaTranslational Research Center for Gastrointestinal Disorders, Laboratory for Brain-Gut Axis Studies, Department of Chronic Diseases and Metabolism, Catholic University of Leuven, 3000 Leuven, Belgium.ORCID 0000-0001-8622-968X
Nathalie WeltensTranslational Research Center for Gastrointestinal Disorders, Laboratory for Brain-Gut Axis Studies, Department of Chronic Diseases and Metabolism, Catholic University of Leuven, 3000 Leuven, Belgium.
Jens F RehfeldDepartment of Clinical Biochemistry, Rigshospitalet, University of Copenhagen, 1172 Copenhagen, Denmark.
Christoph BeglingerSt. Clara Research Ltd. at St. Claraspital, 4002 Basel, Switzerland.
Lukas Van OudenhoveTranslational Research Center for Gastrointestinal Disorders, Laboratory for Brain-Gut Axis Studies, Department of Chronic Diseases and Metabolism, Catholic University of Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-6540-3113
Bettina K WölnerhanssenSt. Clara Research Ltd. at St. Claraspital, 4002 Basel, Switzerland.ORCID 0000-0003-3134-2743
Anne Christin Meyer-GerspachSt. Clara Research Ltd. at St. Claraspital, 4002 Basel, Switzerland.ORCID 0000-0003-4104-8812
University of Basel · CHKU Leuven · BEDartmouth College · USSt. Claraspital · CHUniversity of Copenhagen · DK

Funding

Swiss National Science Foundation 320030E_189329
6 · The paper itself

Abstract

The impact of oral erythritol on subsequent energy intake is unknown. The aim was to assess the effect of oral erythritol compared to sucrose, sucralose, or tap water on energy intake during a subsequent ad libitum test meal and to examine the release of cholecystokinin (CCK) in response to these substances. In this randomized, crossover trial, 20 healthy volunteers received 50 g erythritol, 33.5 g sucrose, or 0.0558 g sucralose dissolved in tap water, or tap water as an oral preload in four different sessions. Fifteen minutes later, a test meal was served and energy intake was assessed. At set time points, blood samples were collected to quantify CCK concentrations. The energy intake (ad libitum test meal) was significantly lower after erythritol compared to sucrose, sucralose, or tap water (p < 0.05). Before the start of the ad libitum test meal, erythritol led to a significant increase in CCK compared to sucrose, sucralose, or tap water (p < 0.001). Oral erythritol given alone induced the release of CCK before the start of the ad libitum test meal and reduced subsequent energy intake compared to sucrose, sucralose, or tap water. These properties make erythritol a useful sugar alternative.

Indexed as

Energy IntakeErythritolCholecystokininCross-Over StudiesHumansSucroseWaterCholecystokininErythritolSucroseWatercholecystokininenergy intakeerythritolgastrointestinal satiation hormonehealthy participantslow-caloric sweetenerssucralosesucrose

Identifiers

PMID36235571
PMCPMC9571225
OpenAlexW4296641971

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.